Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. It offers injectable mouse nerve growth factor, human interferon, vaccines, traditional Chinese medicine decoction pieces, and pharmaceutical distribution. The company was founded in 1998 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd.
Research context
Shandong Sinobioway Biomedicine Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Shandong Sinobioway Biomedicine Co., Ltd is currently in a long term uptrend where the price is trading 4.3% above its 200 day moving average.
From a valuation standpoint, the stock is 318.5% more expensive than other stocks from the Basic Materials sector with a price to sales ratio of 16.8.
Shandong Sinobioway Biomedicine Co., Ltd's total revenue sank by 59.2% to $55M since the same quarter in the previous year.
Its net income has dropped by 157.6% to $-14M since the same quarter in the previous year.
Finally, its free cash flow grew by 413.6% to $26M since the same quarter in the previous year.
Based on the above factors, Shandong Sinobioway Biomedicine Co., Ltd gets an overall score of 2/5.